We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | -2.30% | 2.125 | 2.10 | 2.15 | 2.22 | 2.10 | 2.22 | 642,577 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 0 | -3.81M | -0.0114 | -1.84 | 7M |
From Apr 2019 to Apr 2024
TIDMIMM
RNS Number : 6483Z
Immupharma PLC
20 March 2012
FOR IMMEDIATE RELEASE 20 MARCH 2012
ImmuPharma plc
Notification of Full Year Results
Date: 27 March 2012
ImmuPharma plc (AIM: IMM), the specialist drug development company, is scheduled to announce its Preliminary Results for the year ended 31 December 2011 on Tuesday 27 March 2012.
A lunch briefing for analysts and private client brokers will be held at 12.00pm on the day of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
- Ends -
For further information please contact:
ImmuPharma plc + 44 (0) 20 7152 4080 Dimitri Dimitriou, Chief Executive Officer Lisa Baderoon, Head of Investor Relations lisa.baderoon@immupharma.com + 44 (0) 7721 413496 Buchanan + 44 (0) 20 7466 5000 Mark Court, Jessica Fontaine Panmure, Gordon & Co., NOMAD & Broker +44 (0) 20 7459 3600 Andrew Burnett Rakesh Sharma Espirito Santo Investment Bank +44 (0) 20 7456 9191 James Bromhead Richard Crawley
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKMGMFNLMGZZM
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
